The Valens Company to Hold Conference Call to Discuss Financial Results for the Third Quarter of 2020

KELOWNA, BC, Oct. 6, 2020 /CNW/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce it will issue its third quarter 2020 financial results, for the period ended August 31, 2020 on Wednesday, October 14, 2020, after markets close. CONFERENCE CALLContinue reading “The Valens Company to Hold Conference Call to Discuss Financial Results for the Third Quarter of 2020”

The Valens Company Manufactures Record Number of Product SKUs in the Third Quarter of Fiscal 2020

– The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”),a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced that 56 white label and custom manufacturing product SKUs were produced in the third quarter of 2020, a 56% increase from 36 SKUs in the second quarter of 2020.Continue reading “The Valens Company Manufactures Record Number of Product SKUs in the Third Quarter of Fiscal 2020”

The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart

 –The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company“), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, today announced its participation in a Medical Cannabis Real-World Evidence Study (the “MC-RWE Study“) led by Dr. Hance Clarke of the University Health Network (UHN) in Toronto, Canada. The study will explore theContinue reading “The Valens Company Announces Participation in First-of-its-Kind Real-World Evidence Study on Medical Cannabis Led by the University Health Network in Partnership with Shoppers Drug Mart”

The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2020

– The Valens Company Inc. (formerly Valens GroWorks Corp.) (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce it will issue its second quarter 2020 financial results, for the period ended May 31, 2020, on Wednesday, July 15, 2020, after markets close. CONFERENCE CALLContinue reading “The Valens Company to Hold Conference Call to Discuss Financial Results for the Second Quarter of 2020”

The Valens Company Announces Results of Annual General and Special Meeting of Shareholders

KELOWNA, BC, June 12, 2020 /CNW/ –Valens GroWorks Corp.(TSX: VLNS) (OTCQX: VLNCF) (“Valens” or “The Valens Company“), a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, is pleased to announce the voting results from The Valens Company’s Annual General and Special Meeting of Shareholders (the “Meeting“), held by way of live audio webcast on June 12, 2020. TheContinue reading “The Valens Company Announces Results of Annual General and Special Meeting of Shareholders”